The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...

The third temporary extension, which prolongs the pandemic-era flexibilities through the end of 2025, is a relief for telehealth groups who had raised concerns about access to medications. During the ...

The Drug Enforcement Administration and the HHS announced on Friday they will extend pandemic-era telehealth prescribing flexibilities for controlled substances through 2024. The temporary extension ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

The company has recently announced an upgrade to the platform’s legislative coverage, which has been expanded to include Argentina, Saudi Arabia, and Indonesia. Users can enter any chemical into ...

Washington — The Louisiana House approved legislation Tuesday that would classify the drugs used in medication abortions as controlled substances, criminalizing possession of the drugs without a ...